Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study - Lane, A; Green, F; Scarabin, PY (Atherosclerosis, 1996)
et al.